Definitive Healthcare Corp
$ 1.03
-1.90%
17 Apr - close price
- Market Cap 107,607,000 USD
- Current Price $ 1.03
- High / Low $ 1.08 / 1.03
- Stock P/E N/A
- Book Value 2.70
- EPS -1.30
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.40 %
- 52 Week High 4.70
- 52 Week Low 0.92
About
Definitive Healthcare Corp (DH) is a premier provider of data and analytics solutions tailored for the healthcare sector, serving a wide array of clients including pharmaceutical firms, payers, and healthcare providers. By leveraging extensive datasets and real-time analytics, the company enhances operational performance and provides strategic insights that lead to improved patient outcomes. In an environment marked by increasing complexity and demand for healthcare analytics, Definitive Healthcare is strategically positioned to deliver innovative solutions that drive operational excellence and competitive advantage for its partners. With a commitment to enhancing healthcare delivery through data-driven insights, DH is at the forefront of transforming the healthcare landscape.
Analyst Target Price
$2.49
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-19 | 2025-11-06 | 2025-08-04 | 2025-05-05 | 2025-02-26 | 2024-11-07 | 2024-08-05 | 2024-05-07 | 2024-02-28 | 2023-11-02 | 2023-08-14 | 2023-05-04 |
| Reported EPS | 0.06 | 0.07 | 0.07 | 0.05 | 0.08 | 0.1 | 0.09 | 0.08 | 0.07 | 0.09 | 0.08 | 0.06 |
| Estimated EPS | 0.061 | 0.06 | 0.05 | 0.0248 | 0.0718 | 0.08 | 0.09 | 0.08 | 0.08 | 0.06 | 0.06 | 0.04 |
| Surprise | -0.001 | 0.01 | 0.02 | 0.0252 | 0.0082 | 0.02 | 0 | 0 | -0.01 | 0.03 | 0.02 | 0.02 |
| Surprise Percentage | -1.6393% | 16.6667% | 40% | 101.6129% | 11.4206% | 25% | 0% | 0% | -12.5% | 50% | 33.3333% | 50% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.0 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DH
2026-04-13 14:39:43
This page provides access to Definitive Healthcare (DH) SEC filings, including 10-K, 10-Q, 8-K, and insider trading reports, enhanced with AI-powered summaries and sentiment analysis. It features details on the company's operations, governance, and financial reporting, catering to investors and traders. The most recent filing discussed is an 8-K from July 1, 2025, and a Form 3 insider filing from June 18, 2025, noting the new Chief Legal Officer holds no DH shares.
2026-04-10 04:10:17
Definitive Healthcare Corp. (NASDAQ: DH) has filed a Form 8-K with the SEC announcing the termination of a material definitive agreement, specifically the Nominating Agreement, on April 3, 2026. This action could impact board composition and corporate governance, potentially leading to price sensitivity for its stock. Investors are advised to monitor future disclosures for further clarity on the long-term implications.
2026-04-09 21:09:12
Definitive Healthcare (DH) has officially ended its 2021 nominating agreement with private equity affiliate Spectrum, concluding Spectrum’s special board nomination rights. This follows the resignation of Spectrum designee Jeff Haywood from Definitive Healthcare’s board on March 30, 2026. The move simplifies the company's governance structure and is seen as a step away from private equity influence.
2026-04-09 20:10:17
Definitive Healthcare Corp. (NASDAQ:DH) has terminated its Nominating Agreement with SE VII DHC AIV, L.P. (Spectrum) following the resignation of Spectrum's designated director, Jeff Haywood, from the company's board. The agreement, which allowed Spectrum to nominate a board member if it held at least 5% of the common stock, was formally ended on April 3. This change follows recent financial results where Definitive Healthcare beat revenue expectations but missed on EPS, and saw a lowered price target from Stephens.
2026-04-09 20:09:12
Definitive Healthcare (DH) announced the termination of a Nominating Agreement with SE VII DHC AIV, L.P. (Spectrum) on April 3, 2026. This agreement, originally dated September 17, 2021, had granted Spectrum the right to designate one person for Definitive Healthcare's board slate as long as Spectrum beneficially owned at least 5% of the company's common stock. Jeff Haywood, the Spectrum Designee, resigned from the board on March 30, 2026, fully terminating the nomination rights.
2026-04-09 20:09:12
Definitive Healthcare (NASDAQ:DH) has terminated its Nominating Agreement with SE VII DHC AIV, L.P., also known as Spectrum, following the resignation of Spectrum's designated board member, Jeff Haywood. This agreement had previously granted Spectrum the right to nominate a director if they held at least 5% of the company's outstanding common stock. The termination, effective April 3, 2026, irrevocably ends future nomination rights.
